Universidad de Costa Rica is live on SOPHiA GENETICS’ technology Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Universidad de Costa Rica El Centro de Investigación en Cirugía y Cáncer (CICICA) is now live on the SOPHiA DDM™ […]
Latest enterprise software release of Genedata Screener increases data quality and accelerates project cycles Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new release of Genedata Screener®, its enterprise platform for automated assay data analytics and consolidated assay information management across an enterprise. The new version […]
BOZEMAN, Mont. — Golden Helix, Inc. announces the release of VSPGx, a pharmacogenomics solution for hospitals and testing labs. The field of pharmacogenetics bridges genetics and pharmacology, with the aim of optimizing drug therapies for individual patients based on their unique genetic makeup. It has the potential to revolutionize healthcare by improving drug efficacy, reducing adverse reactions, […]
We are happy to welcome our new portfolio company Cryocloud! Together with Nina Capital and ROM Utrecht Region we have invested € 500K to help the company in their mission to accelerate protein structure determination. We believe the company holds great promise to expand the use of CryoEM in drug development, with their cloud-based data […]
New Expert Forensic Software Enables Users to Investigate Interpretation of Complex Next Generation Sequencing Mixtures The team that created STRmix™ – sophisticated forensic software used to resolve mixed DNA profiles previously thought to be too complex to interpret – is launching STRmix™ NGS (Next Generation Sequencing). NGS, also known as MPS (Massively Parallel Sequencing), is […]
ZURICH, Switzerland BC Platforms AG (hereafter “BC Platforms”) today announces that Tero Silvola, current CEO, is leaving the company, effective today. A new Executive office has been formed with current COO, Mikaela Bruhammar, appointed as interim CEO, together with CFO Kaj Työppönen. During his 10 years tenure, Tero Silvola played a pivotal role in advancing […]
Metabolon’s cutting-edge bioinformatics platform and unique knowledge base will enable customers to leverage the company’s extensive biochemistry experience. MORRISVILLE, NC – Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced at Biomarkers UK the launch of its latest innovation: an […]
Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the launch of Semeta™, a metabolism prediction platform tailored specifically for drug metabolism […]
QIAGEN Biomedical KB-AI contains over 640 million biomedical relationships, including gene, disease and drug causal relationships, to aid in data-driven drug discovery AI-driven insights complement human-curated QIAGEN Biomedical KB-HD and help identify novel relationships between diseases, biological pathways and molecular interactions that may be missed by traditional methods Workflow cuts down on hypothesis testing time and speeds […]
BOZEMAN, Mont. — Golden Helix, Inc. announces the release of VSPGx, a pharmacogenomics solution for hospitals and testing labs. The field of pharmacogenetics bridges genetics and pharmacology, with the aim of optimizing drug therapies for individual patients based on their unique genetic makeup. It has the potential to revolutionize healthcare by improving drug efficacy, reducing adverse reactions, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
